Adebrelimab and Chemoradiotherapy in High-risk LANPC — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(4 sites)
China
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Sun Yat-sen University Cancer Center, Guangzhou, Guangdong West China Hospital, Sichuan University, Chengdu, Sichuan Age range
18 Years – 65 Years
Last updated January 2025